Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how much the NHS has spent on respiratory medicines in each of the last five years.
The cost of respiratory medicines to the National Health Service, by primary and secondary care, in England from years 2012 to 2016 is shown in the following table.
| Primary Care Net Ingredient Cost (£) | Secondary Care Cost (£) | Total Cost (£) |
2012 | 1,009,505,840 | 39,842,049 | 1,049,347,889 |
2013 | 1,020,038,047 | 39,938,913 | 1,059,976,960 |
2014 | 1,032,783,044 | 38,983,420 | 1,071,766,464 |
2015 | 1,044,951,211 | 38,600,943 | 1,083,552,154 |
2016 | 1,034,877,082 | 38,547,801 | 1,073,424,883 |
Source: Prescription Cost Analysis; 2016 QuintilesIMS: Hospital Pharmacy Audit Index
These figures do not include costs for treating respiratory infections or cancers, as the medicines required (antibiotics and chemotherapy) are used for other therapy areas and are not specific to respiratory disease. These costs are at list prices, and discounts achieved by hospitals and community pharmacy have not been included.